Pharmacol 240, 319-323, (1993). Bergeron, R., Debonnel, G., & De Montigny, C. View abstract in PubMed Post navigationPreviousPrevious post:Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex.NextNext post:Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer’s disease correlates with CA1 pyramidal cell loss.Related PostsAnavex Life Sciences Announces Initiation of First-in-Human Phase 1 Study of ANAVEX®3-71 (AF710B)May 21, 2020 Anavex Life Sciences Reports Fiscal 2020 Second Quarter Financial Results And Provides Business UpdatesMay 7, 2020Anavex Life Sciences to Announce Fiscal 2020 Second Quarter Financial Results on Thursday, May 7th, 2020May 5, 2020Anavex Life Sciences Reports Fiscal 2020 First Quarter Financial Results And Provides Clinical Study UpdatesFebruary 6, 2020
Anavex Life Sciences Announces Initiation of First-in-Human Phase 1 Study of ANAVEX®3-71 (AF710B)May 21, 2020
Anavex Life Sciences Reports Fiscal 2020 Second Quarter Financial Results And Provides Business UpdatesMay 7, 2020
Anavex Life Sciences to Announce Fiscal 2020 Second Quarter Financial Results on Thursday, May 7th, 2020May 5, 2020
Anavex Life Sciences Reports Fiscal 2020 First Quarter Financial Results And Provides Clinical Study UpdatesFebruary 6, 2020
